Abstract
The treatment of hepatocellular carcinoma (HCC) has undergone evolution and refinement over the past three decades. Changes in the understanding of HCC with respect to tumor size, number and location, underlying liver function and portal pressure, and hepatic anatomy, in combination with refinement of surgical techniques and technologies, have greatly influenced the approach to surgical management. Surgery is considered the mainstay of curative HCC treatment with resection and transplantation achieving the best outcomes in well-selected candidates (5-year survival of 60–80 %). Surgical resection of HCC, especially within the Milano/Mazzaferro criteria (i.e., solitary tumor ≤ 5 cm or up to three tumors all ≤ 3 cm) in patients with well-preserved liver function (Child-Pugh A and selectively B patients), offers the greatest chances for survival. Liver transplantation is considered the treatment of choice for patients with compromised liver function (Child-Pugh B/C). The clinical parameters identified in this Chapter will be used to generate Digital Patient Models (DPMs) to facilitate diagnosis, prognosis, and treatment selection, i.e. Model Guided Therapy (MGT). The following have been identified as key issues relating to Predictive, Preventive, and Personalized Medicine (PPPM) and surgical treatment for HCC: tumor characterization, such as size, number, and vascular invasion; the patientʼs clinical status, particularly the presence of cirrhosis, the degree of portal hypertension, and liver functional reserve; pre-operative management, such as patient selection for resection or transplantation, choice of donor, down-staging and bridging therapies; and, surgical techniques, including techniques to minimize blood loss and to ensure an adequate liver remnant.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Bruix J, Sherman M (2011) AASLD practice guideline. Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022
Bruix J, Sherman M (2010) AASLD Practice Guideline. Management of hepatocellular carcinoma. Hepatology Supplement:1–32. http://www.aasld.org/practiceguidelines/Documents/ Bookmarked%20Practice%20Guidelines/HCCUpdate2010.pdf. Accessed 20 Nov 2011
European Association for the Study of the Liver. European Organisation for Research and Treatment of Cancer (2012) EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56: 908–943
Aronsohn A, Mohanty SR (2010) Current treatment strategies for hepatocellular carcinoma. Curr Cancer Ther Rev 6:199–206
Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42:1208–1236
El-Serag HB, Marrero JA, Rudolph L et al (2008) Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134:1752–1763
Llovet JM, Fuster J, Bruix J (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30:1434–1440
Bruix J, Castells A, Bosch J et al (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111:1018–1022
Vauthey JN, Ribero D, Abdalla EK et al (2007) Outcomes of liver transplantation in 490 patients with hepatocellular carcinoma: validation of a uniform staging after surgical treatment. J Am Coll Surg 204:1016–1028
Okada S, Shimada K, Yamamoto J et al (1994) Predictive factors for postoperative recurrence of hepatocellular carcinoma. Gastroenterology 106:1618–1624
Ikai I, Arii S, Kojiro M et al (2004) Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey. Cancer 101:796–802
Earl TM, Chapman WC (2011) Conventional surgical treatment of Hepatocellular Carcinoma. Clin Liver Dis 15:353–370
Chen YJ, Yeh SH, Chen JT et al (2000) Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology 119:431–440
Roayaie S, Blume IN, Thung SN, et al (2009) A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 137:850–855
Shi M, Guo RP, Lin XJ et al (2007) Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial. Ann Surg 245:36–43
Yamasaki S, Hasegawa H, Kinoshita H et al (1996) A prospective randomized trial of the preventive effect of pre-operative transcatheter arterial embolization against recurrence of hepatocellular carcinoma. Jpn J Cancer Res 87:206–211
Farges O, Belghiti J, Kianmanesh R al (2003) Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg 237:208–217
Abulkhir A, Limongelli P, Healey AJ, et al (2008) Preoperative portal vein embolization for major liver resection: a metaanalysis. Ann Surg 247:49–57
Makuuchi M, Sano K (2004) The surgical approach to HCC: our progress and results in Japan. Liver Transpl 10:S46–S52
Mazzaferro V, Regalia E, Doci R et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693–699
Shetty K, Timmins K, Brensinger C et al (2004) Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl 10:911–918
Yao FY, Ferrell L, Bass NM et al (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33:1394–1403
Freeman RB Jr, Wiesner RH, Harper A et al (2002) The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 8:851–858
Liver transplant candidates with hepatocellular carcinoma. (2008) http://unos.org/PoliciesandBylaws2/policies/pdfs/policy_8.pdf
Ioannou GN, Perkins JD, Carithers RL Jr (2008) Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 134:1342–1351
Yao FY, Hirose R, LaBerge JM et al (2005) A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 11:1505–1514
Freeman RB Jr, Steffick DE, Guidinger MK et al (2008) Liver and intestine transplantation in the United States, 1997–2006. Am J Transplant 8:958–976
Masuoka HC, Rosen CB (2011) Liver transplantation for hepatocellular carcinoma: expanding frontiers and building bridges. Clin Liver Dis 15:385–393
Schwartz M, Konstadoulakis M, Roayaie S (2005) Recurrence of hepatocellular carcinoma after liver transplantation: is immunosuppression a factor? Liver Transpl 11:494–496
Schwartz ME, Sung M, Mor E et al (1995) A multidisciplinary approach to hepatocellular carcinoma in patients with cirrhosis. J Am Coll Surg 180:596–603
Olthoff KM, Merion RM, Ghobrial RM et al (2005) Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg 242:314–325
Fisher RA, Kulik LM, Freise CE et al (2007) Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 7:1601–1608
Brown RS, Jr Russo MW, Lai M et al (2003) A survey of liver transplantation from living adult donors in the United States. N Engl J Med 348:818–825
Kulkarni S, Malago M, Cronin DC 2nd. (2006) Living donor liver transplantation for pediatric and adult recipients. Nat Clin Pract Gastroenterol Hepatol 3:149–157
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Mohanty, S., Berliner, L., Shah, S. (2015). Surgical Treatment for Hepatocellular Carcinoma. In: Berliner, L., Lemke, H. (eds) An Information Technology Framework for Predictive, Preventive and Personalised Medicine. Advances in Predictive, Preventive and Personalised Medicine, vol 8. Springer, Cham. https://doi.org/10.1007/978-3-319-12166-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-12166-6_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12165-9
Online ISBN: 978-3-319-12166-6
eBook Packages: MedicineMedicine (R0)